Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dheeraj A Shinde"'
Autor:
Hyrije Ademi, Dheeraj A Shinde, Max Gassmann, Daniela Gerst, Hassan Chaachouay, Johannes Vogel, Thomas A Gorr
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0251765 (2021)
Since growing tumors stimulate angiogenesis, via vascular endothelial growth factor (VEGF), angiogenesis inhibitors (AIs, blockers of the VEGF signaling pathway) have been introduced to cancer therapy. However, AIs often yielded only modest and short
Externí odkaz:
https://doaj.org/article/4d0d39519819418880f3c2187cac7b0b
Autor:
Thomas A. Gorr, Max Gassmann, Pavel Hradecky, Hubert Rehrauer, Dheeraj A. Shinde, Daniela Wichmann, Claudia Setzer, Daniel P. Stiehl, Junmin Hu
PDF file - 347K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ba18d7bcb73470566f75594804c730
https://doi.org/10.1158/1541-7786.22518585
https://doi.org/10.1158/1541-7786.22518585
Autor:
Thomas A. Gorr, Max Gassmann, Pavel Hradecky, Hubert Rehrauer, Dheeraj A. Shinde, Daniela Wichmann, Claudia Setzer, Daniel P. Stiehl, Junmin Hu
Rampant activity of the hypoxia-inducible factor (HIF)-1 in cancer is frequently associated with the malignant progression into a harder-to-treat, increasingly aggressive phenotype. Clearly, anti-HIF strategies in cancer cells are of considerable cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13a036472826306efade220873b54bce
https://doi.org/10.1158/1541-7786.c.6542010.v1
https://doi.org/10.1158/1541-7786.c.6542010.v1
Publikováno v:
Procedia Manufacturing. 20:296-299
The objective of this research was to find out whether using a specially developed isometric template helps students to reduce time and efforts while drawing isometric drawings. The standard method of comparison of performance of two groups has been
Autor:
Claudia Setzer, Max Gassmann, Daniela Wichmann, Dheeraj A. Shinde, Hubert Rehrauer, Daniel P. Stiehl, Pavel Hradecky, Thomas A. Gorr, Junmin Hu
Publikováno v:
Molecular cancer research : MCR
Rampant activity of the hypoxia-inducible factor (HIF)-1 in cancer is frequently associated with the malignant progression into a harder-to-treat, increasingly aggressive phenotype. Clearly, anti-HIF strategies in cancer cells are of considerable cli
Autor:
Mandy Joerschke, Georg W. Herget, Angelina Meier, Till Braunschweig, Udo Kontny, Andrej Lissat, Rachel Bortnick, Thomas A. Gorr, Philipp Henneke, Anna Makowska, Dheeraj A. Shinde
Publikováno v:
BMC cancer 15(1), 552 (2015). doi:10.1186/s12885-015-1564-7
BMC Cancer
BMC Cancer
BMC cancer 15(1), 552 (2015). doi:10.1186/s12885-015-1564-7
Published by BioMed Central, London
Published by BioMed Central, London
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab124c0518c69c15749eb40cdcc1393
https://refubium.fu-berlin.de/handle/fub188/16510
https://refubium.fu-berlin.de/handle/fub188/16510